Related Experiment Video
Updated: May 3, 2026

11:17
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
Published on: August 11, 2018
13.8K
The case against anergy testing as a routine adjunct to tuberculin skin testing
B S Slovis1, J D Plitman, D W Haas
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn, USA.
JAMA
|May 2, 2000
Summary
Anergy testing does not improve the interpretation of negative tuberculin skin tests for tuberculosis screening or diagnosis. Its results do not predict disease progression, making it unreliable for clinical decisions.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- Tuberculin skin testing (TST) is a common method for screening latent tuberculosis infection and guiding isoniazid prophylaxis.
- Anergy testing, using control antigens, is sometimes employed to interpret non-reactive TST results.
- Concerns exist regarding the standardization and validity of anergy testing protocols and interpretation.
Purpose of the Study:
- To evaluate the clinical utility and validity of anergy testing in interpreting negative tuberculin skin test results.
- To determine if anergy testing aids in diagnosing tuberculosis or predicting disease progression.
Main Methods:
- Review of existing literature and clinical practices regarding anergy testing and tuberculin skin testing.
- Analysis of the impact of control antigen reactivity on TST interpretation and clinical decision-making.
- Assessment of anergy testing's predictive value for tuberculosis progression in HIV-negative and HIV-positive individuals.
Main Results:
- Anergy testing lacks standardized protocols for antigen selection, response criteria, and interpretation.
- Reactivity to control antigens does not influence decisions regarding latent tuberculosis infection or prophylaxis.
- Anergy testing results do not predict the risk of progression to active tuberculosis in any patient group.
- Negative TST results, even with positive reactions to other antigens, do not rule out latent or active tuberculosis.
Conclusions:
- Anergy testing is not a useful tool for screening asymptomatic tuberculosis infection.
- Anergy testing does not aid in the diagnosis of active tuberculosis.
- Microbiologic evaluation remains essential when tuberculosis infection is suspected, irrespective of TST or anergy test results.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Pulmonary Tuberculosis III
1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pulmonary Tuberculosis IV
828
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
828
Pulmonary Tuberculosis V
1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K

